XCNQ
TAAT
Market cap0kUSD
, Last price
CAD
Name
TAAT Global Alternatives Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
63.15%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
95m
+122.45%
Net income
-11m
L-54.87%
CFO
-1m
L-88.67%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Incorporated in 2006 and headquartered in Toronto, Canada, TAAT Global Alternatives Inc. is a life sciences enterprise focused on creating, producing, and distributing smokable goods that do not contain tobacco. Operating under its TAAT brand, the company provides substitutes for traditional cigarettes that are entirely free of both nicotine and tobacco for markets in Canada and the United States. The firm adopted its current name, TAAT Global Alternatives Inc., in April 2021, having previously been known as TAAT Lifestyle & Wellness Ltd.
Key people
Interim Chief Executive Officer, Chief Financial Officer, Corporate Secretary, Director · since 2025
Michael Saxon
Chief Executive Officer, Director · since 2022
John Cumming
Independent Director · since 2016
Joseph Deighan
Independent Director · since 2020
John Martin
Independent Director · since 2021
Peter Nguyen
Independent Director · since 2021
Legal address
Suite 810 - 789 West Pender Street
Vancouver, BC V6C1H2
CA
Vancouver, BC V6C1H2
CA
Headquarters
Suite 2630, 1075 West Georgia Street
Vancouver, BC V6E 3C9
CA
Vancouver, BC V6E 3C9
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑10 | 2022‑10 | 2021‑10 | 2020‑10 | 2019‑10 | 2018‑10 | 2017‑10 | 2016‑10 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||